33.81
전일 마감가:
$34.69
열려 있는:
$32.4
하루 거래량:
434.26K
Relative Volume:
0.50
시가총액:
$237.32M
수익:
-
순이익/손실:
$-112.46M
주가수익비율:
-20.62
EPS:
-1.64
순현금흐름:
$-99.89M
1주 성능:
+11.22%
1개월 성능:
-17.94%
6개월 성능:
+99.52%
1년 성능:
+122.43%
보 바이오파마 Stock (VOR) Company Profile
명칭
Vor Biopharma Inc
전화
617-655-6580
주소
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
VOR을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
VOR
Vor Biopharma Inc
|
33.81 | 237.32M | 0 | -112.46M | -99.89M | -1.64 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
381.87 | 96.56B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
449.58 | 60.08B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
555.51 | 61.15B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
711.09 | 44.66B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
328.71 | 36.23B | 3.81B | -644.79M | -669.77M | -6.24 |
보 바이오파마 Stock (VOR) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-06-30 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
2022-07-26 | 개시 | Wedbush | Outperform |
2022-04-27 | 개시 | Goldman | Neutral |
2021-12-17 | 개시 | H.C. Wainwright | Buy |
2021-12-03 | 개시 | Robert W. Baird | Outperform |
2021-12-02 | 개시 | Oppenheimer | Outperform |
2021-10-19 | 개시 | JMP Securities | Mkt Outperform |
2021-03-25 | 개시 | B. Riley Securities | Buy |
2021-03-03 | 개시 | Barclays | Overweight |
2021-03-03 | 개시 | Evercore ISI | Outperform |
2021-03-02 | 개시 | Goldman | Sell |
2021-03-02 | 개시 | Stifel | Buy |
모두보기
보 바이오파마 주식(VOR)의 최신 뉴스
Vor Biopharma: Transformed Company Is A High Risk Buy On Autoimmune Disease Promise - Seeking Alpha
Vor Biopharma Shares Slide Following Warrant Registration Filing - MSN
Vor Biopharma stock drops after filing to register warrant shares By Investing.com - Investing.com Nigeria
Vor Biopharma stock drops after filing to register warrant shares - Investing.com
Stifel upgrades Vor Biopharma stock to Buy on telitacicept prospects By Investing.com - Investing.com South Africa
Vor Biopharma (VOR) Registers 51M Shares for Resale, Warrants in Focus - GuruFocus
Vor Biopharma files for offering of up to 51 million common shares by the selling stockholdersSEC filing - MarketScreener
Vor Biopharma (VOR) files for 51M share offering by selling stockholders - StreetInsider
Vor Biopharma upgraded to Buy at Stifel on telitacicept prospects - Seeking Alpha
Stifel upgrades Vor Biopharma stock to Buy on telitacicept prospects - Investing.com India
Stifel Nicolaus Upgrades Vor Biopharma (NYSE:VOR) to Buy - MarketBeat
Vor Biopharma climbs after Stifel upgrades rating on autoimmune drug potential - TradingView
Vor Biopharma (NYSE:VOR) Stock Price Down 8.6% Following Insider Selling - MarketBeat
Vor Biopharma’s Strategic Moves and Telitacicept’s Potential Drive Buy Rating Amid Stock Decline - TipRanks
Vor Bio appoints Navid Khan as chief medical affairs officer By Investing.com - Investing.com South Africa
Vor Bio appoints Navid Khan as chief medical affairs officer - Investing.com
Vor Biopharma (VOR) Sees Significant Increase in Borrow Rate - GuruFocus
Vor Bio Appoints Navid Z. Khan, Ph.D., as Chief Medical Affairs Officer - GlobeNewswire
7 Successful Drug Launches: Vor Bio Taps VYVGART Launch Veteran Navid Khan as Medical Affairs Chief - Stock Titan
Vor Biopharma (NASDAQ:VOR) Shares Down 7.2%What's Next? - MarketBeat
Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 22,363 Shares - MarketBeat
Analysts Set Vor Biopharma Inc. (NYSE:VOR) Price Target at $6.07 - MarketBeat
Street Watch: Is Vor Biopharma Inc stock overvalued or fairly pricedTrade Entry Summary & Proven Capital Preservation Tips - خودرو بانک
Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 447,278 Shares - MarketBeat
Insider Selling: Vor Biopharma (NYSE:VOR) Major Shareholder Sells 20,000 Shares of Stock - MarketBeat
Momentum Shift: What is the PEG ratio of Vor Biopharma IncQuarterly Trade Report & Entry Point Confirmation Signals - خودرو بانک
Insider Selling: Vor Biopharma (NYSE:VOR) Major Shareholder Sells 14,240 Shares of Stock - MarketBeat
Risk Report: Is Vor Biopharma Inc. part of any ETF2025 Price Action Summary & Verified Swing Trading Watchlists - khodrobank.com
Reprogrammed Interchange Llc Sells 300,000 Shares of Vor Biopharma (NYSE:VOR) Stock - MarketBeat
Vor Biopharma Inc. recovery potential after sell offInflation Watch & Weekly Stock Performance Updates - newser.com
How to interpret RSI for Vor Biopharma Inc. stockMarket Performance Summary & Verified Technical Signals - newser.com
Will Vor Biopharma Inc. rebound enough to break evenPortfolio Profit Report & Fast Moving Stock Watchlists - newser.com
Vor Biopharma ten percent owner sells $688k in shares By Investing.com - Investing.com Australia
Vor Biopharma (VOR) Faces Trading Halt Amid Reverse Stock Split and Share Sale - GuruFocus
Vor Biopharma trading halted on Thursday, news pending (VOR:NASDAQ) - Seeking Alpha
Relative strength of Vor Biopharma Inc. in sector analysis2025 Momentum Check & Real-Time Chart Pattern Alerts - newser.com
Will Vor Biopharma Inc. bounce back from current supportWeekly Investment Report & Weekly Watchlist for Hot Stocks - newser.com
What momentum shifts mean for Vor Biopharma Inc.Market Activity Report & Reliable Entry Point Trade Alerts - newser.com
What’s the recovery path for long term holders of Vor Biopharma Inc.July 2025 Pullbacks & Low Risk High Reward Ideas - newser.com
Vor Biopharma ten percent owner sells $688k in shares - Investing.com
Using Bollinger Bands to evaluate Vor Biopharma Inc.Portfolio Gains Summary & Community Consensus Picks - newser.com
Gains Report: Is Vor Biopharma Inc stock overvalued or fairly pricedWeekly Trend Report & AI Driven Price Predictions - khodrobank.com
Vor Biopharma Announces 1-for-20 Reverse Stock Split - TipRanks
Vor Biopharma (NASDAQ:VOR) Rating Increased to Hold at Zacks Research - MarketBeat
Vor Bio Announces Oral Presentation of 48-Week China Phase - GlobeNewswire
Vor Biopharma announces 1-for-20 reverse stock split effective Thursday - Investing.com India
Weekly Recap: How cyclical is Vor Biopharma Inc.’s revenue stream2025 Market Outlook & High Win Rate Trade Tips - khodrobank.com
CEO Moves: Can Vor Biopharma Inc keep up with sector leadersJuly 2025 Highlights & Daily Market Momentum Tracking - خودرو بانک
보 바이오파마 (VOR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
보 바이오파마 주식 (VOR) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Reprogrammed Interchange LLC | 10% Owner |
Sep 15 '25 |
Sale |
1.64 |
400,000 |
656,320 |
33,228,487 |
Reprogrammed Interchange LLC | 10% Owner |
Sep 12 '25 |
Sale |
1.75 |
300,000 |
526,230 |
33,628,487 |
Reprogrammed Interchange LLC | 10% Owner |
Sep 11 '25 |
Sale |
1.83 |
284,805 |
521,421 |
33,928,487 |
Reprogrammed Interchange LLC | 10% Owner |
Sep 08 '25 |
Sale |
1.99 |
464,421 |
924,058 |
35,012,518 |
Reprogrammed Interchange LLC | 10% Owner |
Sep 09 '25 |
Sale |
2.00 |
449,226 |
898,632 |
34,563,292 |
Reprogrammed Interchange LLC | 10% Owner |
Sep 10 '25 |
Sale |
1.82 |
350,000 |
635,285 |
34,213,292 |
Reprogrammed Interchange LLC | 10% Owner |
Sep 03 '25 |
Sale |
2.00 |
554,612 |
1,107,061 |
36,329,955 |
Reprogrammed Interchange LLC | 10% Owner |
Sep 04 '25 |
Sale |
1.93 |
453,016 |
873,641 |
35,876,939 |
Reprogrammed Interchange LLC | 10% Owner |
Sep 05 '25 |
Sale |
1.97 |
400,000 |
787,280 |
35,476,939 |
자본화:
|
볼륨(24시간):